Mental Health: The Five Year Plan
- 08:30 - 16:20
- America Square Conference Centre, London
Magstim is a leading provider of rTMS (repetitive Transcranial Magnetic Stimulation) therapy products for the treatment of Major Depressive Disorder.
rTMS provides a new treatment choice for patients unable to undergo, or who have failed to respond to, traditional pharmaceutical options.
With no systemic side effects and the ability to perform the treatment as part of an outpatient procedure, clinicians internationally are turning to rTMS therapy as a proven treatment for Major Depressive Disorder.
With 25 years of leading TMS research behind its name, Magstim offers a complete solution for clinicians who are seeking an innovative and effective option for treatment.
Learn more about why NHS trusts are adopting rTMS treatment at www.magstim.com